IOL CHEMICALS & PHARM. | STRIDES PHARMA SCIENCE | IOL CHEMICALS & PHARM./ STRIDES PHARMA SCIENCE |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.9 | -1,653.2 | - | View Chart |
P/BV | x | 1.6 | 3.7 | 42.3% | View Chart |
Dividend Yield | % | 1.0 | 0.2 | 585.5% |
IOL CHEMICALS & PHARM. STRIDES PHARMA SCIENCE |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
STRIDES PHARMA SCIENCE Mar-23 |
IOL CHEMICALS & PHARM./ STRIDES PHARMA SCIENCE |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 392 | 136.8% | |
Low | Rs | 272 | 263 | 103.3% | |
Sales per share (Unadj.) | Rs | 377.6 | 408.5 | 92.5% | |
Earnings per share (Unadj.) | Rs | 23.7 | -25.6 | -92.7% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 1.4 | 2,307.2% | |
Dividends per share (Unadj.) | Rs | 4.00 | 1.50 | 266.7% | |
Avg Dividend yield | % | 1.0 | 0.5 | 216.1% | |
Book value per share (Unadj.) | Rs | 256.8 | 242.8 | 105.8% | |
Shares outstanding (eoy) | m | 58.71 | 90.30 | 65.0% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 0.8 | 133.4% | |
Avg P/E ratio | x | 17.1 | -12.8 | -133.1% | |
P/CF ratio (eoy) | x | 12.8 | 239.6 | 5.3% | |
Price / Book Value ratio | x | 1.6 | 1.4 | 116.7% | |
Dividend payout | % | 16.9 | -5.9 | -287.7% | |
Avg Mkt Cap | Rs m | 23,743 | 29,603 | 80.2% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 7,320 | 23.0% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 36,884 | 60.1% | |
Other income | Rs m | 256 | 1,352 | 18.9% | |
Total revenues | Rs m | 22,427 | 38,236 | 58.7% | |
Gross profit | Rs m | 2,257 | 830 | 272.0% | |
Depreciation | Rs m | 462 | 2,433 | 19.0% | |
Interest | Rs m | 165 | 2,611 | 6.3% | |
Profit before tax | Rs m | 1,887 | -2,862 | -65.9% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | -553 | -89.5% | |
Profit after tax | Rs m | 1,391 | -2,309 | -60.3% | |
Gross profit margin | % | 10.2 | 2.2 | 452.4% | |
Effective tax rate | % | 26.2 | 19.3 | 135.8% | |
Net profit margin | % | 6.3 | -6.3 | -100.2% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 31,353 | 30.8% | |
Current liabilities | Rs m | 5,025 | 29,902 | 16.8% | |
Net working cap to sales | % | 20.9 | 3.9 | 532.3% | |
Current ratio | x | 1.9 | 1.0 | 183.5% | |
Inventory Days | Days | 43 | 71 | 60.8% | |
Debtors Days | Days | 8 | 129 | 6.5% | |
Net fixed assets | Rs m | 11,017 | 31,300 | 35.2% | |
Share capital | Rs m | 587 | 903 | 65.0% | |
"Free" reserves | Rs m | 14,490 | 21,025 | 68.9% | |
Net worth | Rs m | 15,077 | 21,928 | 68.8% | |
Long term debt | Rs m | 0 | 11,398 | 0.0% | |
Total assets | Rs m | 20,684 | 63,734 | 32.5% | |
Interest coverage | x | 12.5 | -0.1 | -12,979.1% | |
Debt to equity ratio | x | 0 | 0.5 | 0.0% | |
Sales to assets ratio | x | 1.1 | 0.6 | 185.2% | |
Return on assets | % | 7.5 | 0.5 | 1,585.4% | |
Return on equity | % | 9.2 | -10.5 | -87.6% | |
Return on capital | % | 13.6 | -0.8 | -1,809.4% | |
Exports to sales | % | 26.7 | 46.7 | 57.3% | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | 17,213 | 34.5% | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 18,113 | 32.7% | |
Fx outflow | Rs m | 6,052 | 672 | 901.2% | |
Net fx | Rs m | -122 | 17,442 | -0.7% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 444 | 275.3% | |
From Investments | Rs m | -1,200 | 3,025 | -39.7% | |
From Financial Activity | Rs m | -41 | -2,139 | 1.9% | |
Net Cashflow | Rs m | -18 | 1,328 | -1.4% |
Indian Promoters | % | 48.2 | 25.9 | 186.2% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 42.6 | 4.0% | |
FIIs | % | 1.4 | 24.6 | 5.7% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 74.1 | 69.9% | |
Shareholders | 130,003 | 84,695 | 153.5% | ||
Pledged promoter(s) holding | % | 0.0 | 72.7 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES SUN PHARMA CIPLA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | STRIDES PHARMA SCIENCE | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 2.31% | -0.13% | 1.25% |
1-Month | 7.19% | 15.06% | 1.32% |
1-Year | 2.05% | 163.92% | 54.08% |
3-Year CAGR | -12.49% | -0.69% | 14.76% |
5-Year CAGR | 16.53% | 13.38% | 19.32% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the STRIDES PHARMA SCIENCE share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of STRIDES PHARMA SCIENCE the stake stands at 25.9%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of STRIDES PHARMA SCIENCE.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
STRIDES PHARMA SCIENCE paid Rs 1.5, and its dividend payout ratio stood at -5.9%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of STRIDES PHARMA SCIENCE.
For a sector overview, read our pharmaceuticals sector report.
Japan's Nikkei 225 led gains in Asia as markets in the region rose across the board, following Wall Street's continued rally for a second straight day.